tiprankstipranks
Trending News
More News >

Orthocell Expands US Distribution Network for Remplir™

Story Highlights
Orthocell Expands US Distribution Network for Remplir™

Confident Investing Starts Here:

Orthocell Ltd ( (AU:OCC) ) has shared an announcement.

Orthocell Ltd has rapidly expanded its US distribution network for its nerve repair product, Remplir™, appointing 12 distributors across 21 states, surpassing its initial target. This strategic expansion, following FDA clearance, is expected to significantly boost the company’s revenue and market penetration in the US$1.6 billion nerve repair market, leveraging experienced distributors and internal sales teams to drive growth.

More about Orthocell Ltd

Orthocell Ltd is a regenerative medicine company specializing in products for nerve repair. Its flagship product, Remplir™, is a collagen wrap used in nerve repair surgery to enhance outcomes in the repair and regeneration of damaged nerves. The company is targeting a large global nerve repair market, with regulatory approvals in several countries and applications pending in others.

Average Trading Volume: 1,615,638

Technical Sentiment Signal: Buy

Current Market Cap: A$375.1M

Learn more about OCC stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1